<i>β</i>-Catenin Does Not Confer Tumorigenicity When Introduced into Partially Transformed Human Mesenchymal Stem Cells

<table>Osteogenic differentiation as demonstrated by staining with Alizarin Red 21 days after induction, 10x magnifications.</table>

Sarcoma

Figure 5: <i>β</i>-Catenin Does Not Confer Tumorigenicity When Introduced into Partially Transformed Human Mesenchymal Stem Cells 